Veracyte | VCYT - Ebit


Veracyte reported $23.11M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Agenus USD -13.31M 19.08M Mar/2025
Agilent USD 443M 66M Sep/2025
Anika Therapeutics USD -4.28M 3.58M Mar/2025
Arrowhead Research USD 40.81M 17.01M Dec/2025
Bruker USD 76.3M 7.6M Dec/2025
Exact Sciences USD -25M 22.85M Sep/2025
Heron Therapeutics USD -4.46M 5.76M Sep/2024
Illumina USD 256M 6M Dec/2025
Intrexon USD -26.3M 2.91M Jun/2024
Karyopharm Therapeutics USD -26.28M 1.84M Sep/2024
Laboratory Of America USD 382M 11M Dec/2025
Ligand Pharmaceuticals USD 158.89M 115.32M Sep/2025
Myriad Genetics USD -5.5M 11.1M Mar/2025
Rigel Pharmaceuticals USD 447K 1.52M Jun/2024
Roche Holding CHF 9.56B 2.1B Dec/2025
Siemens EUR 2.57B 3M Dec/2025
Sonic Healthcare AUD 423.94M 80.3M Dec/2024
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Veracyte USD 23.11M 8.8M Sep/2025
Waters USD 270.52M 78.4M Dec/2025